Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warren, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Bellerophon Therapeutics, Inc. has filed 643 SEC EDGAR filings since 21 Feb 2014

SEC filing history

Showing 426-450 of 643 matching filings.

Per page
25
Current page
18
8-K File 001-36845

8-K

Filing date
12 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-211166

424B5

Filing date
11 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
05 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
02 May 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
01 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36845

DEFA14A

Filing date
20 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36845

DEF 14A

Filing date
20 Mar 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-36845

10-K/A

Filing date
17 Mar 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
16 Mar 2017
Reporting date
10 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
16 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
13 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88741

SC 13G

Filing date
01 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88741

SC 13G/A

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88741

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
06 Jan 2017
Reporting date
06 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88741

ARCH VENTURE FUND VI, L.P. - SCHEDULE 13DA - AMEND. #1 (BELLEROPHON THERAPEUTICS

Filing date
04 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .